Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 18 Neoplasms 6 Rectal Neoplasms 4 Colonic Neoplasms 4 Neoplasm Metastasis 3 Squamous Cell Carcinoma of Head and Neck 2 Head and Neck Neoplasms 2 Tongue Neoplasms 1 Pancreatic Neoplasms 1 Oesophago-gastric Cancer 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Cancer Metastatic 1

Interventions

aflibercept 3 Irinotecan 2 Bevacizumab 2 XELOX 1 Vemurafenib 1 Panitumumab 1 Leucovorin 1 IFL protocol 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colorectal Cancer Metastatic × Panitumumab × Clear all

NCT01910610 2024-03-12

STRATEGIC-1

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Unknown

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡